Alerts will be sent to your verified email
Verify EmailALBERTDAVD
|
Albert David
|
Shivalik Rasayan
|
Prevest Denpro
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
0.84 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
11.47 % | 6.54 % | 19.0 % |
|
5yr average Equity Multiplier
|
1.63 | 1.82 | 1.07 |
|
5yr Average Asset Turnover Ratio
|
0.62 | 0.44 | 0.6 |
|
5yr Avg Net Profit Margin
|
11.31 % | 7.94 % | 29.64 % |
|
Price to Book
|
1.04 | 0.69 | 4.36 |
|
P/E
|
0.0 | 35.22 | 25.45 |
|
5yr Avg Cash Conversion Cycle
|
-77.77 Days | 100.7 Days | 42.6 Days |
|
Inventory Days
|
47.91 Days | 80.64 Days | 36.0 Days |
|
Days Receivable
|
27.87 Days | 107.04 Days | 44.41 Days |
|
Days Payable
|
140.35 Days | 166.18 Days | 39.32 Days |
|
5yr Average Interest Coverage Ratio
|
93.73 | 8.55 | 99.71 |
|
5yr Avg ROCE
|
14.69 % | 8.54 % | 25.39 % |
|
5yr Avg Operating Profit Margin
|
9.55 % | 17.6 % | 36.91 % |
|
5 yr average Debt to Equity
|
0.02 | 0.2 | 0.0 |
|
5yr CAGR Net Profit
|
-4.92 % | -1.04 % | 2.94 % |
|
5yr Average Return on Assets
|
7.03 % | 3.57 % | 17.71 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
62.24 % | 47.37 % | 73.6 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.2 % | -2.95 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Albert David
|
Shivalik Rasayan
|
Prevest Denpro
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|
|
Dosage Form Break-Up
|
Dosage Form Break-Up
|
-
|
-
|
|
Customer Wise Break-Up
|
Customer Wise Break-Up
|
-
|
-
|